BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kumar D, Ferreira VH, Hall VG, Hu Q, Samson R, Ku T, Ierullo M, Majchrzak-Kita B, Tomlinson G, Gingras AC, Humar A. Neutralization of SARS-CoV-2 Variants in Transplant Recipients After Two and Three Doses of mRNA-1273 Vaccine : Secondary Analysis of a Randomized Trial. Ann Intern Med 2021. [PMID: 34807716 DOI: 10.7326/M21-3480] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 22.0] [Reference Citation Analysis]
Number Citing Articles
1 Kodali L, Budhiraja P, Gea-banacloche J. COVID-19 in kidney transplantation-implications for immunosuppression and vaccination. Front Med 2022;9. [DOI: 10.3389/fmed.2022.1060265] [Reference Citation Analysis]
2 Panizo N, Giménez E, Albert E, Zulaica J, Rodríguez-moreno A, Rusu L, Giménez-civera E, Puchades MJ, D’marco L, Gandía-salmerón L, Torres I, Sancho A, Gavela E, Gonzalez-rico M, Montomoli M, Perez-baylach CM, Bonilla B, Solano C, Alvarado MF, Torregrosa I, Gonzales-candia B, Alcaraz MJ, Geller R, Górriz JL, Navarro D. SARS-CoV-2-Spike Antibody and T-Cell Responses Elicited by a Homologous Third mRNA COVID-19 Dose in Hemodialysis and Kidney Transplant Recipients. Microorganisms 2022;10:2275. [DOI: 10.3390/microorganisms10112275] [Reference Citation Analysis]
3 Zhang X, Weng R, Liu F, Xie Y, Jin Y, Li Q, Huang G, Chen J, Wang J, Shen H, Fu H, Mao J. COVID-19 Breakthrough Infections in Vaccinated Kidney Transplant Recipients. Vaccines 2022;10:1911. [DOI: 10.3390/vaccines10111911] [Reference Citation Analysis]
4 Bailey AJ, Maganti HB, Cheng W, Shorr R, Arianne Buchan C, Allan DS. Humoral and Cellular Response of Transplant Recipients to a Third Dose of mRNA SARS-CoV-2 Vaccine: A Systematic Review and Meta-analysis. Transplantation 2022;Publish Ahead of Print. [DOI: 10.1097/tp.0000000000004386] [Reference Citation Analysis]
5 Pinto-Álvarez M, Fernández-Niño JA, Arregocés-Castillo L, Rojas-Botero ML, Palacios AF, Galvis-Pedraza M, Ruiz-Gomez F. Real-world Evidence of COVID-19 Vaccines Effectiveness in Solid-organ Transplant Recipient Population in Colombia: A Study Nested in the Esperanza Cohort. Transplantation 2022. [PMID: 36228269 DOI: 10.1097/TP.0000000000004411] [Reference Citation Analysis]
6 El-Menyar A, Khan NA, Mekkodathil A, Rizoli S, Consunji R, Elmenyar E, Galwankar S, Al-Thani H. A quick scoping review of the first year of vaccination against the COVID-19 pandemic: Do we need more shots or time? Medicine (Baltimore) 2022;101:e30609. [PMID: 36123868 DOI: 10.1097/MD.0000000000030609] [Reference Citation Analysis]
7 Nakazawa H, Sakai K, Sudo Y, Iwabuchi R, Sakai H, Nishina S, Kawakami T, Kawakami F, Matsuzawa S, Ito T, Kitahara M, Kamijo Y, Umemura T, Ushiki A, Kanai S, Tsuchiya H, Ishida F. Comparative analysis of humoral responses to BNT162b2 vaccine among patients with hematologic disorders and organ transplant recipients. Transpl Immunol 2022;75:101713. [PMID: 36100196 DOI: 10.1016/j.trim.2022.101713] [Reference Citation Analysis]
8 Ascaso-del-rio A, García-pérez J, Pérez-olmeda M, Arana-arri E, Vergara I, Pérez-ingidua C, Bermejo M, Castillo de la Osa M, Imaz-ayo N, Riaño Fernández I, Astasio González O, Díez-fuertes F, Meijide S, Arrizabalaga J, Hernández Gutiérrez L, de la Torre-tarazona HE, Mariano Lázaro A, Vargas-castrillón E, Alcamí J, Portolés A. Immune response and reactogenicity after immunization with two-doses of an experimental COVID-19 vaccine (CVnCOV) followed by a third-fourth shot with a standard mRNA vaccine (BNT162b2): RescueVacs multicenter cohort study. eClinicalMedicine 2022;51:101542. [DOI: 10.1016/j.eclinm.2022.101542] [Reference Citation Analysis]
9 Benning L, Morath C, Kühn T, Bartenschlager M, Kim H, Beimler J, Buylaert M, Nusshag C, Kälble F, Reineke M, Töllner M, Schaier M, Klein K, Blank A, Schnitzler P, Zeier M, Süsal C, Bartenschlager R, Tran TH, Speer C. Humoral response to SARS-CoV-2 mRNA vaccination in previous non-responder kidney transplant recipients after short-term withdrawal of mycophenolic acid. Front Med 2022;9. [DOI: 10.3389/fmed.2022.958293] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Bárczi E, Varga V, Nagy A, Eszes N, Jáky‐kováts Z, Müller V, Bohács A. Serological findings following the second and third SARS‐CoV‐2 vaccines in lung transplant recipients. Immunity Inflam & Disease 2022;10. [DOI: 10.1002/iid3.646] [Reference Citation Analysis]
11 Kim WJ, Choi SH, Park JY, Song JS, Chung JW, Choi ST. SARS-CoV-2 Omicron escapes mRNA vaccine booster-induced antibody neutralisation in patients with autoimmune rheumatic diseases: an observational cohort study. Ann Rheum Dis 2022:annrheumdis-2022-222689. [PMID: 35878999 DOI: 10.1136/ard-2022-222689] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Tobudic S, Benazzo A, Koblischke M, Schneider L, Blüml S, Winkler F, Schmidt H, Vorlen S, Haslacher H, Perkmann T, Burgmann H, Jaksch P, Aberle JH, Winkler S. Immune Response after mRNA COVID-19 Vaccination in Lung Transplant Recipients: A 6-Month Follow-Up. Vaccines (Basel) 2022;10:1130. [PMID: 35891294 DOI: 10.3390/vaccines10071130] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Meng Z, Ma D, Duan S, Zhang J, Yue R, Li X, Gao Y, Li X, Zeng F, Xu X, Jiang G, Liao Y, Fan S, Niu Z, Li D, Yu L, Zhao H, Xu X, Wang L, Zhang Y, Liu L, Li Q. Immunological Study of Combined Administration of SARS-CoV-2 DNA Vaccine and Inactivated Vaccine. Vaccines (Basel) 2022;10:929. [PMID: 35746536 DOI: 10.3390/vaccines10060929] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Hall VG, Al-Alahmadi G, Solera JT, Marinelli T, Cardinal H, Prasad GVR, De Serres SA, Isaac D, Mainra R, Lamarche C, Sapir-Pichhadze R, Gilmour S, Matelski J, Humar A, Kumar D. Outcomes of SARS-CoV-2 Infection in Unvaccinated Compared With Vaccinated Solid Organ Transplant Recipients: A Propensity Matched Cohort Study. Transplantation 2022. [PMID: 35502801 DOI: 10.1097/TP.0000000000004178] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
15 Solera JT, Árbol BG, Alshahrani A, Bahinskaya I, Marks N, Humar A, Kumar D. Impact of Vaccination and Early Monoclonal Antibody Therapy on COVID-19 Outcomes in Organ Transplant Recipients During the Omicron Wave. Clin Infect Dis 2022:ciac324. [PMID: 35445690 DOI: 10.1093/cid/ciac324] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
16 Manothummetha K, Chuleerarux N, Sanguankeo A, Kates OS, Hirankarn N, Thongkam A, Dioverti-Prono MV, Torvorapanit P, Langsiri N, Worasilchai N, Moonla C, Plongla R, Garneau WM, Chindamporn A, Nissaisorakarn P, Thaniyavarn T, Nematollahi S, Permpalung N. Immunogenicity and Risk Factors Associated With Poor Humoral Immune Response of SARS-CoV-2 Vaccines in Recipients of Solid Organ Transplant: A Systematic Review and Meta-Analysis. JAMA Netw Open 2022;5:e226822. [PMID: 35412626 DOI: 10.1001/jamanetworkopen.2022.6822] [Cited by in Crossref: 13] [Cited by in F6Publishing: 18] [Article Influence: 13.0] [Reference Citation Analysis]
17 Papalois V, Kotton CN, Budde K, Torre-cisneros J, Croce D, Halleck F, Roze S, Grossi P. Impact of COVID-19 on Global Kidney Transplantation Service Delivery: Interim Report. Transpl Int 2022;35:10302. [DOI: 10.3389/ti.2022.10302] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Al Jurdi A, Gassen RB, Borges TJ, Solhjou Z, Hullekes FE, Lape IT, Efe O, Alghamdi A, Patel P, Choi JY, Mohammed MT, Bohan B, Pattanayak V, Rosales I, Cravedi P, Kotton CN, Azzi JR, Riella LV. Non-Invasive Monitoring for Rejection in Kidney Transplant Recipients After SARS-CoV-2 mRNA Vaccination. Front Immunol 2022;13:838985. [PMID: 35281011 DOI: 10.3389/fimmu.2022.838985] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
19 Salleh MZ, Norazmi MN, Deris ZZ. Immunogenicity mechanism of mRNA vaccines and their limitations in promoting adaptive protection against SARS-CoV-2. PeerJ 2022;10:e13083. [DOI: 10.7717/peerj.13083] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
20 Jurdi AA, Gassen RB, Borges TJ, Lape IT, Morena L, Efe O, Solhjou Z, Fekih RE, Deban C, Bohan B, Pattanayak V, Kotton CN, Azzi JR, Riella LV. Diminished antibody response against SARS-CoV-2 Omicron variant after third dose of mRNA vaccine in kidney transplant recipients.. [DOI: 10.1101/2022.01.03.22268649] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]